Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo ; volume:8 ; number:1 ; day:28 ; month:11 ; year:2007 ; pages:1-10 ; date:12.2007
BMC immunology ; 8, Heft 1 (28.11.2007), 1-10, 12.2007
- Creator
-
Frommhold, David
Mannigel, Ingrid
Schymeinsky, Jürgen
Mocsai, Attila
Poeschl, Johannes
Walzog, Barbara
Sperandio, Markus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2172-8-31
- URN
-
urn:nbn:de:101:1-2021080921084543755101
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frommhold, David
- Mannigel, Ingrid
- Schymeinsky, Jürgen
- Mocsai, Attila
- Poeschl, Johannes
- Walzog, Barbara
- Sperandio, Markus
- SpringerLink (Online service)
Other Objects (12)
Spleen Tyrosine Kinase (SYK) im multiplen Myelom und Beeinflussung des Myeloms durch den SYK Inhibitor R406
Regulation der „spleen tyrosine kinase“ Syk im B-Zell-Antigen-Rezeptor-Signalweg
Spleen tyrosine kinase (SYK) als potentielle Zielstruktur in der Behandlung des kutanen Lupus erythematodes
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Analyse der Syk (Spleen-Tyrosine-Kinase)-Inhibition auf anti-proliferative und pro-apopstotische Effekte, die Migration und Viabilität von Zellen beim Multiplen Myelom
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
Role of tyrosine kinase Syk in thrombus stabilisation at high shear
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets : = Untersuchungen der Thrombopoese und der spleen tyrosine kinase-vermittelten Signaltransduktion in Thrombozyten
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
Analysis of the cytoplasmic tyrosine kinase Syk at the interface between lymphocyte and vascular development
Spleen Tyrosine Kinase (SYK) im multiplen Myelom und Beeinflussung des Myeloms durch den SYK Inhibitor R406
Regulation der „spleen tyrosine kinase“ Syk im B-Zell-Antigen-Rezeptor-Signalweg
Spleen tyrosine kinase (SYK) als potentielle Zielstruktur in der Behandlung des kutanen Lupus erythematodes
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Analyse der Syk (Spleen-Tyrosine-Kinase)-Inhibition auf anti-proliferative und pro-apopstotische Effekte, die Migration und Viabilität von Zellen beim Multiplen Myelom
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
Role of tyrosine kinase Syk in thrombus stabilisation at high shear
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets : = Untersuchungen der Thrombopoese und der spleen tyrosine kinase-vermittelten Signaltransduktion in Thrombozyten
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
Analysis of the cytoplasmic tyrosine kinase Syk at the interface between lymphocyte and vascular development
Spleen Tyrosine Kinase (SYK) im multiplen Myelom und Beeinflussung des Myeloms durch den SYK Inhibitor R406
Regulation der „spleen tyrosine kinase“ Syk im B-Zell-Antigen-Rezeptor-Signalweg
Spleen tyrosine kinase (SYK) als potentielle Zielstruktur in der Behandlung des kutanen Lupus erythematodes
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Analyse der Syk (Spleen-Tyrosine-Kinase)-Inhibition auf anti-proliferative und pro-apopstotische Effekte, die Migration und Viabilität von Zellen beim Multiplen Myelom
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
Role of tyrosine kinase Syk in thrombus stabilisation at high shear
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets : = Untersuchungen der Thrombopoese und der spleen tyrosine kinase-vermittelten Signaltransduktion in Thrombozyten
Studies on thrombopoiesis and spleen tyrosine kinase-mediated signaling in platelets
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer